Label: MUCUS RELIEF- guaifenesin 400 mg tablet
- NDC Code(s): 82725-1012-1
- Packager: Cabinet Health, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated November 11, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each tablet)
- Purpose
- Uses
-
Warnings
ask a doctor before use if you have
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis or emphysema
- cough accompanied by excessive phlegm (mucus)
- Directions:
- Other information
- Inactive ingredients
- Questions or Comments
- Principal Display Panel
-
INGREDIENTS AND APPEARANCE
MUCUS RELIEF
guaifenesin 400 mg tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:82725-1012 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN 400 mg Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4) MAGNESIUM STEARATE (UNII: 70097M6I30) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) STEARIC ACID (UNII: 4ELV7Z65AP) POVIDONE (UNII: FZ989GH94E) MALTODEXTRIN (UNII: 7CVR7L4A2D) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) Product Characteristics Color white Score no score Shape OVAL Size 17mm Flavor Imprint Code S400 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:82725-1012-1 200 in 1 BOTTLE; Type 0: Not a Combination Product 11/01/2024 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M012 11/01/2024 Labeler - Cabinet Health, Inc. (117102391)